The cannabis market has remained extremely lucrative for some time now, but August has been a month in waiting for the upcoming recreational market to take place next month in Canada. As stocks around the industry ready themselves for this new and high demand period, it seems as though now is a better time than ever to get involved in the cannabis space.
One of the companies that many have been watching and one that remains quite large in the market is the company Insys Therapeutics (NASDAQ:INSY). The company currently has a market cap of around $560 million and a share price that still remains relatively low at around $8. According to one report “It is also developing Cannabidiol Oral Solution, which has completed a pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain.” Only a few key players in the cannabis space have been working to get their cannabis-based pharmaceuticals approved by federal agencies, but this seems to be an increasing part of the overall market share.
The next company on the list is the company CannTrust Holdings (NASDAQOTH:CNTTF). CannTrust has been one of the major Canadian marijuana producers and one of the only companies in the space that has reported three consecutive profitable quarters. According to one report “CannTrust already has two production facilities that together have close to 500,000 square feet of growing space. The company has also started construction of an even larger facility. When this facility is ready, CannTrust will have total annual production capacity of more than 100,000 kilograms.” This amount of production is quite large in the way of the cannabis market, and as stated before, could help to deal with the new and high demand for cannabis throughout Canada. One of the ways that companies are working to defeat any potential of an oversupply is through the use of export. Companies are working to export their products into abroad markets such as that of Germany and beyond which will likely help their profits as well. The company according to the same report already has “supply agreements for recreational marijuana with three provinces — British Columbia, Alberta, and Manitoba.” For this reason, CannTrust seems to be poised perfectly to continue taking advantage of the growing cannabis space.
The last company on the list is the company Marapharm Ventures (MRPHF) Marapharm Ventures according to one report “is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.” The company is also in the right spot to take advantage of the fast-paced cannabis market in the coming years.
The hopes are high that the companies mentioned above can continue to perform well as the next months and years fly by.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Marapharm Ventures, Midam has been paid $200,000 from the company and ZERO shares of Marapharm Ventures Inc. for a duration beginning June 27, 2018 and ending July 27, 2018. We may buy or sell additional shares of (MRPHF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
